Y-90 radioembolization for liver cancer: what the assessment involves
Y-90 radioembolization, also called TARE or selective internal radiation therapy, delivers radioactive microspheres into arteries supplying a liver tumor. Suitability depends on tumor distribution, liver reserve and where the particles would travel. A mapping assessment helps the team plan treatment and protect other organs. For patients comparing liver-directed options, the useful question is what Y-90 is intended to achieve and how it compares with the other approaches that fit the same disease pattern.
On this page
Establish the goal of radioembolization
A liver-directed treatment may aim to control a selected tumor, manage disease that cannot be removed, or support a later treatment pathway in carefully chosen patients. The goal affects how the team plans the treatment and judges its success.
Ask whether the proposal addresses all important disease or only the liver component. If cancer has spread elsewhere, the team also needs a plan for those sites. Confirm that the assessment is for HCC, because cancer that has spread to the liver from another organ has its own treatment sequence.
Why a mapping procedure comes first
Mapping examines the arteries supplying the liver and the risk of particles reaching other organs. A tracer study can help assess distribution, including passage toward the lungs. The findings inform whether treatment can proceed and how it should be delivered.
Ask which findings would change or stop the proposed treatment. A plan made from a CT report alone may be refined after the vascular assessment. Clarify whether mapping and treatment are separate visits and how much flexibility your travel arrangements need.
Sources and references: [3]
The liver assessment still determines suitability
The team reviews liver function, the volume of liver to be treated and previous therapies. Underlying cirrhosis can increase the risk that treatment reduces liver function. A small targeted treatment and treatment to a large liver volume can place different demands on reserve.
Bring a history of jaundice, abdominal fluid or previous liver complications. Ask what the team expects the untreated liver to do during recovery. The discussion should compare the planned cancer control with the risk to the functioning liver that remains.
Compare Y-90 with the relevant alternatives
Depending on the case, alternatives may include surgery, ablation, TACE, external radiation or systemic therapy. The comparison should use the same treatment goal and disease extent. A local treatment that fits one liver lesion may be unsuitable for a different pattern.
Ask what feature favors Y-90: location, distribution, the intended treatment area or another anatomical issue. If the recommendation is based on a possible future operation, ask who will reassess that option and what milestones would support it.
Sources and references: [1]
Prepare for the treatment visit
The team provides instructions for medicines, fasting and the procedure day. Radioembolization is delivered through an arterial catheter by a specialist team. The amount and distribution of radiation are planned for the particular treatment.
Request the names of the clinicians responsible for the procedure and follow-up. Ask who to call if symptoms develop once you have left the hospital. If you use blood thinners, have kidney disease or have reacted to contrast, make sure those details are reviewed during preparation.
Sources and references: [3]
Plan around recovery and radiation instructions
Fatigue, reduced appetite or abdominal discomfort can follow treatment. Liver injury and unintended radiation to other tissues are important risks to discuss. The service should give specific aftercare and radiation-safety instructions based on the product and procedure.
Before booking a long journey, ask when travel is appropriate and whether any temporary contact precautions apply. Arrange help with meals and transport if needed. New jaundice, worsening pain, persistent vomiting or significant illness should be assessed through the treating team's urgent pathway.
Know when the response will be judged
The follow-up plan uses imaging and blood tests to evaluate both tumor activity and liver function. Radiation effects evolve over time, so ask when the first scan will be meaningful and how early changes will be interpreted.
Keep the mapping report, treatment summary and dosimetry information if supplied. These records matter if later surgery, another radiation treatment or another liver-directed procedure is considered. Ask what result would support observation, another local treatment or a change to systemic therapy.
Organizing a Shanghai treatment comparison
Zhongshan Hospital is a relevant liver cancer resource for assessing options. A consultation should first establish whether radioembolization fits your case and which service would provide the required planning and treatment.
EastMedGo can help organize the inquiry with your images, liver tests and previous treatment summaries. We can clarify the assessment pathway and any separate mapping and treatment visits. Once the clinical service defines the proposal, we can discuss coordination costs and practical arrangements for follow-up.
Sources and references: [4]
Common questions
Are TARE, Y-90 and SIRT the same term?
They are often used for the same radioembolization approach. Ask which radioactive microsphere product and treatment plan are proposed in your case.
Sources and references: [3]
Can mapping show that treatment should not go ahead?
Yes. Mapping can identify an unfavorable distribution or another issue that changes the plan. It is a safety and planning step, not just an administrative requirement.
Sources and references: [3]
Should I expect the tumor to disappear on the first scan?
Response is assessed over time using imaging and liver tests. The team will explain which scan timing and signs are meaningful after radiation treatment.
Sources and references: [3]
Sources and references
- Liver Cancer Treatment
- Primary Liver Cancer Treatment (PDQ) – Health Professional Version
- Radioembolization (Y90)
- Zhongshan Hospital Affiliated to Fudan University
Prepared with AI assistance by EastMedGo for patients comparing treatment and care options.